Combined dextromethorphan and chlorpheniramine intoxication in impaired drivers

Journal of Forensic Sciences

Volumn 54, Issue 5, 2009, Pages 1176-1180

  Logan, Barry K ^a  

^a 3701 Welsh Rd   (United States)

Author keywords

Chlorpheniramine; Coricidin; Dextromethorphan; Driving impairment; Forensic science; Toxicology

Indexed keywords

CHLORPHENIRAMINE; DEXTROMETHORPHAN; NON PRESCRIPTION DRUG;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; DRIVER; DRIVING ABILITY; DRUG ABUSE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG INTOXICATION; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; TRAFFIC;

ADOLESCENT; ADULT; AUTOMOBILE DRIVING; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CHLORPHENIRAMINE; CHROMATOGRAPHY, GAS; DEXTROMETHORPHAN; FEMALE; FORENSIC TOXICOLOGY; HUMANS; MALE; MIDDLE AGED; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS;

EID: 69649098869     PISSN: 00221198     EISSN: 15564029     Source Type: Journal    
DOI: 10.1111/j.1556-4029.2009.01127.x     Document Type: Article

References (25)

1. Levine DA. "Pharming": the abuse of prescription and over-the-counter drugs in teens. Curr Opin Pediatr 2007 19 (3 270 274.
2. The third plateau. Available at: http://www.third-plateau.org (accessed July 22, 2009).
3. Ball JK, Albright V. Emergency department visits involving dextromethorphan. The DAWN Report, 2006, issue 32. Available at: http://dawninfo.samhsa.gov/files/TNDR10DXM.htm (accessed June 11, 2008).
4. Chyka PA, Erdman AR, Manoguerra AS, Christianson G, Booze LL, Nelson LS, et al. Dextromethorphan poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol 2007 45 (6 662 677. (Pubitemid 47394415)
5. Logan BK, Goldfogel G, Hamilton R, Kuhlman J. Five deaths resulting from abuse of dextromethorphan sold over the internet. J Anal Toxicol 2009 33 (2 99 103.
6. Cochems A, Harding P, Liddicoat L. Dextromethorphan in Wisconsin drivers. J Anal Toxicol 2007 31 (4 227 232.
7. Kosnoski EM, Yolton RL, Citek K, Hayes CE, Evans RB. The drug evaluation classification program: using ocular and other signs to detect drug intoxication. J Am Optom Assoc 1998 69 (4 211 227.
8. Akins BE, Miranda E, Lacy JM, Logan BK. A multi-drug intoxication fatality involving Xyrem® (GHB). J Forensic Sci 2009 54 (2 495 496.
9. Farrell LJ, Kerrigan S, Logan BK. Recommendations for toxicological investigation of drug impaired driving. J Forensic Sci 2007 52 (5 1214 1218. Erratum in: J Forensic Sci 2008;53(1):239.
10. Banerji S, Anderson IB. Abuse of Coricidin HBP cough & cold tablets: episodes recorded by a poison center. Am J Health Syst Pharm 2001 19 : 1811 1814.
11. Streetman DS, Ellis RE, Nafziger AN, Leeder JS, Gaedigk A, Gotschall R, et al. Dose dependency of dextromethorphan for cytochrome P450 2D6 (CYP2D6) phenotyping. Clin Pharmacol Ther 1999 66 (5 535 541.
12. de Zeeuw RA, Jonkman JHG. Genetic differences in oxidative drug metabolism. Proceedings of the 25th Meeting of the International Association of Forensic Toxicologists, 1988 Aug; Groningen, Netherlands. London, UK : The International Association of Forensic Toxicologists, 1988 53 64.
13. Steinberg GK, Bell TE, Yenari MA. Dose escalation safety and tolerance study of the N-methyl-d-aspartate antagonist dextromethorphan in neurosurgery patients. J Neurosurg 1996 84 (5 860 866.
14. Pope LE, Khalil MH, Berg JE, Stiles M, Yakatan GJ, Sellers EM. Pharmacokinetics of dextromethorphan after single or multiple dosing in combination with quinidine in extensive and poor metabolizers. J Clin Pharmacol 2004 44 (10 1132 1142.
15. Hamelin BA, Bouayad A, Drolet B, Gravel A, Turgeon J. In vitro characterization of cytochrome P450 2D6 inhibition by classic histamine H1 receptor antagonists. Drug Metab Dispos 1998 26 (6 536 539.
16. Witherow LE, Houston JB. Sigmoidal kinetics of CYP3A substrates: an approach for scaling dextromethorphan metabolism in hepatic microsomes and isolated hepatocytes to predict in vivo clearance in rat. J Pharm Exp Ther 1999 290 : 58 65.
17. Masumoto K, Tashiro Y, Matsumoto K, Yoshida A, Hirayama M, Hayashi S. Simultaneous determination of codeine and chlorpheniramine in human plasma by capillary column gas chromatography. J Chromatogr 1986 2 : 323 329.
18. Van Toor BS, Buchwald A, Stengele E, Trenk D, Gercek C, de Mey CM. Systemic bioavailability of nasally applied chlorphenamine maleate (0.4% nasalspray) relative to tablets administered perorally. Int J Clin Pharmacol Ther 2001 39 (4 173 178.
19. Brunton LB, Lazo JS, Parker KL, editors. Goodman & Gilman's the pharmacological basis of therapeutics, 11th edn. New York : McGraw-Hill, 2005 651 658.
20. Karamanakos PN, Pappas P, Marselos M. Involvement of the brain serotonergic system in the locomotor stimulant effects of chlorpheniramine in Wistar rats: implication of postsynaptic 5-HT1A receptors. Behav Brain Res 2004 2 : 199 208.
21. Tanda G, Kopajtic TA, Katz JL. Cocaine-like neurochemical effects of antihistaminic medications. J Neurochem 2008 106 (1 147 157.
22. Navarro A, Perry C, Bobo WV. A case of serotonin syndrome precipitated by abuse of the anticough remedy dextromethorphan in a bipolar patient treated with fluoxetine and lithium. Gen Hosp Psychiatry 2006 28 (1 78 80.
23. Alfaro CL, Lam YW, Simpson J, Ereshefsky L. CYP2D6 inhibition by fluoxetine, paroxetine, sertraline, and venlafaxine in a crossover study: intraindividual variability and plasma concentration correlations. J Clin Pharmacol 2000 40 (1 58 66.
24. Theunissen EL, Vermeeren A, Ramaekers JG. Repeated-dose effects of mequitazine, cetirizine and dexchlorpheniramine on driving and psychomotor performance. Br J Clin Pharmacol 2006 61 (1 79 86.
25. Vermeeren A, Ramaekers JG, Van Leeuwen CJ, O'Hanlon JF. Residual effects on actual car driving of evening dosing of chlorpheniramine 8 and 12 mg when used with terfenadine 60 mg in the morning. Human Psychopharmacol 1998 13 : S79 86.